Danica Pension Livsforsikringsaktieselskab Buys New Shares in Danaher Corporation $DHR

Danica Pension Livsforsikringsaktieselskab purchased a new position in Danaher Corporation (NYSE:DHR) during the 2nd quarter, HoldingsChannel.com reports. The firm purchased 21,168 shares of the conglomerate’s stock, valued at approximately $15,242,000.

Several other institutional investors also recently modified their holdings of the stock. Sivia Capital Partners LLC increased its stake in Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares in the last quarter. First Trust Advisors LP lifted its stake in Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after buying an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC boosted its holdings in shares of Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after buying an additional 886 shares during the period. Ieq Capital LLC increased its position in shares of Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after acquiring an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC increased its position in shares of Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after acquiring an additional 325 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of several research analyst reports. JPMorgan Chase & Co. reduced their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Piper Sandler began coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective on the stock. TD Cowen cut their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. Finally, Royal Bank Of Canada lifted their price target on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Stock Up 6.2%

DHR opened at $211.92 on Thursday. The company has a market capitalization of $148.98 billion, a PE ratio of 37.64, a price-to-earnings-growth ratio of 2.49 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The business has a 50-day moving average of $194.30 and a 200-day moving average of $192.44.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.77 EPS. Equities research analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.